- Home
- SKX vs BPMC Comparison
SKX vs BPMC Comparison
Compare SKX & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKX
- BPMC
- Stock Information
- Founded
- SKX 1992
- BPMC 2008
- Country
- SKX United States
- BPMC United States
- Employees
- SKX N/A
- BPMC N/A
- Industry
- SKX Shoe Manufacturing
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- SKX Consumer Discretionary
- BPMC Health Care
- Exchange
- SKX Nasdaq
- BPMC Nasdaq
- Market Cap
- SKX 6.9B
- BPMC 5.8B
- IPO Year
- SKX 1999
- BPMC 2015
- Fundamental
- Price
- SKX $61.52
- BPMC $101.25
- Analyst Decision
- SKX Buy
- BPMC Buy
- Analyst Count
- SKX 13
- BPMC 21
- Target Price
- SKX $70.33
- BPMC $124.05
- AVG Volume (30 Days)
- SKX 10.6M
- BPMC 1.0M
- Earning Date
- SKX 04-24-2025
- BPMC 05-01-2025
- Dividend Yield
- SKX N/A
- BPMC N/A
- EPS Growth
- SKX 9.64
- BPMC N/A
- EPS
- SKX 4.16
- BPMC N/A
- Revenue
- SKX $9,129,335,000.00
- BPMC $562,121,000.00
- Revenue This Year
- SKX $9.70
- BPMC $44.85
- Revenue Next Year
- SKX $8.17
- BPMC $32.06
- P/E Ratio
- SKX $14.76
- BPMC N/A
- Revenue Growth
- SKX 10.66
- BPMC 99.19
- 52 Week Low
- SKX $44.50
- BPMC $73.04
- 52 Week High
- SKX $78.85
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- SKX 68.66
- BPMC 65.95
- Support Level
- SKX $46.74
- BPMC $97.91
- Resistance Level
- SKX $61.64
- BPMC $104.86
- Average True Range (ATR)
- SKX 1.46
- BPMC 3.74
- MACD
- SKX 2.02
- BPMC 1.50
- Stochastic Oscillator
- SKX 97.07
- BPMC 83.26
About SKX Skechers U.S.A. Inc.
Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.